Concepedia

Don Luo

DL

Statistics

Publications

14

Citations

2.2K

H-Index

12

Active since

2003

Affiliations

Pfizer (United States)(Current)

Queen Mary University of London

Janssen (Belgium)

Université Paris Cité

Inova Fairfax Hospital

Don Luo is an author at Pfizer (United States) specializing in pharmacotherapy, pharmacy, and cardiovascular disease.

Publications per year

2003–2024

14

Publications

14

Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease

Prakash Deedwania, Peter H. Stone, C. Noel Bairey Merz et al. · Circulation · 2007 · 235 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Analysis of Efficacy and Safety in Patients Aged 65–75 Years at Randomization

H. A. W. Neil, David A. DeMicco, Don Luo et al. · Diabetes Care · 2006 · 114 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Effects of High-Dose Atorvastatin in Patients ≥65 Years of Age With Acute Coronary Syndrome (from the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering [MIRACL] Study)

Anders Olsson, Gregory G. Schwartz, Michael Szarek et al. · The American Journal of Cardiology · 2007 · 63 citations

Medicine, Cardiology, Pharmacology +16

Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms

Gervais Tougas, Ying Chen, Don Luo et al. · Gastroenterology · 2003 · 62 citations

Medicine, Clinical Sciences, Internal Medicine +11

1–5 of 14